Javascript must be enabled to continue!
Directed evolution of an m6A eraser for site-selective epitranscriptome editing
View through CrossRef
Abstract
N6-methyladenosine (m6A) is a critical RNA modification, but tools to manipulate it in cells remain limited. Current m6A demethylases (FTO and ALKBH5) exhibit low catalytic efficiency, hindering their applications in epitranscriptomic research and biotechnology. Here, we develop a fluorescence-based directed evolution platform that enables rapid selection of m6A demethylases with enhanced activity. Using this platform, we generated FTO-818, an evolved FTO variant with 13-fold increased catalytic efficiency against m6A compared to wild-type FTO. FTO-818 demonstrates superior demethylation performance both on purified biological RNAs in vitro and on endogenous m6A when overexpressed in human cells. Furthermore, we constructed a targeted m6A editor by fusing FTO-818 to catalytically-dead Cas13b (dCas13b-FTO-818), achieving efficient, site-specific removal of m6A from individual mRNA and lncRNA. This directed evolution platform and the resulting FTO-818 enzyme provide powerful new tools for investigating m6A biology and advancing applications in epitranscriptomic research and biotechnology.
Title: Directed evolution of an m6A eraser for site-selective epitranscriptome editing
Description:
Abstract
N6-methyladenosine (m6A) is a critical RNA modification, but tools to manipulate it in cells remain limited.
Current m6A demethylases (FTO and ALKBH5) exhibit low catalytic efficiency, hindering their applications in epitranscriptomic research and biotechnology.
Here, we develop a fluorescence-based directed evolution platform that enables rapid selection of m6A demethylases with enhanced activity.
Using this platform, we generated FTO-818, an evolved FTO variant with 13-fold increased catalytic efficiency against m6A compared to wild-type FTO.
FTO-818 demonstrates superior demethylation performance both on purified biological RNAs in vitro and on endogenous m6A when overexpressed in human cells.
Furthermore, we constructed a targeted m6A editor by fusing FTO-818 to catalytically-dead Cas13b (dCas13b-FTO-818), achieving efficient, site-specific removal of m6A from individual mRNA and lncRNA.
This directed evolution platform and the resulting FTO-818 enzyme provide powerful new tools for investigating m6A biology and advancing applications in epitranscriptomic research and biotechnology.
Related Results
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
Background: N6-methyladenosine (m6A) modification is a part of epigenetic research that has gained increasing attention in recent years. m6A modification is widely involved in many...
Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension
Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension
Abstract
Background: Hypoxic pulmonary hypertension (HPH) is a lethal disease and lacks effective therapy. CircRNAs play significant roles in physiological process. Recentl...
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
Abstract
Background
Polycystic ovary syndrome (PCOS) is a multisystem-related disease whose pathophysiology is still unclear. Several regulators of ...
mRNAs encoding neurodevelopmental regulators have equal m6A stoichiometry in Drosophila neuroblasts and neurons
mRNAs encoding neurodevelopmental regulators have equal m6A stoichiometry in Drosophila neuroblasts and neurons
Abstract
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification in metazoans and is particularly abundant in the central nervous system. The extent to wh...
Prognostic value of comprehensive typing based on m6A and gene cluster
Prognostic value of comprehensive typing based on m6A and gene cluster
Abstract
Background
Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy because it lacks the estrog...
Current progress in strategies to profile transcriptomic m6A modifications
Current progress in strategies to profile transcriptomic m6A modifications
Various methods have been developed so far for detecting N6-methyladenosine (m6A). The total m6A level or the m6A status at individual positions on mRNA can be detected and quantif...
P1621m6A RNA-methylation in the progression of heart failure
P1621m6A RNA-methylation in the progression of heart failure
Abstract
Introduction
N6-Methyladenosine (m6A) is the most abundant modification of RNA and was found to be a dynamic and revers...
Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences
Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences
AbstractThe N6-methyladenosine (m6A) modification is deposited to nascent transcripts on chromatin, but its site-specificity mechanism is mostly unknown. Here we model the m6A depo...

